First Time Loading...

Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 12.45 CNY -2.89% Market Closed
Updated: May 12, 2024

Wall Street
Price Targets

Price Targets Summary
Hunan Fangsheng Pharmaceutical Co Ltd

Wall Street analysts forecast Hunan Fangsheng Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hunan Fangsheng Pharmaceutical Co Ltd is 10.52 CNY with a low forecast of 10.41 CNY and a high forecast of 10.83 CNY.

Lowest
Price Target
10.41 CNY
16% Downside
Average
Price Target
10.52 CNY
16% Downside
Highest
Price Target
10.83 CNY
13% Downside
Hunan Fangsheng Pharmaceutical Co Ltd Competitors:
Price Targets
ATAI
ATAI Life Sciences NV
477% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
36% Downside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
28% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
8% Upside
PLTH
Planet 13 Holdings Inc
191% Upside
RVNC
Revance Therapeutics Inc
358% Upside
CURA
Curaleaf Holdings Inc
41% Upside
NECLIFE
Nectar Lifesciences Ltd
26% Upside

Revenue
Forecast

Revenue Estimate
Hunan Fangsheng Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's revenue is 17%. The projected CAGR for the next 2 years is 19%.

17%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Hunan Fangsheng Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 2 years is 35%.

10%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Hunan Fangsheng Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's net income is 9%. The projected CAGR for the next 2 years is 27%.

9%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hunan Fangsheng Pharmaceutical Co Ltd's stock price target?
Price Target
10.52 CNY

According to Wall Street analysts, the average 1-year price target for Hunan Fangsheng Pharmaceutical Co Ltd is 10.52 CNY with a low forecast of 10.41 CNY and a high forecast of 10.83 CNY.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's revenue is 17%. The projected CAGR for the next 2 years is 19%.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
35%

For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 2 years is 35%.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's net income is 9%. The projected CAGR for the next 2 years is 27%.